Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma

被引:234
作者
Bourguignon, Lilly Y. W.
Wong, Gabriel
Earle, Christine
Chen, Liqun
机构
[1] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N2, San Francisco, CA 94121 USA
[2] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MARKER NANOG; IN-VITRO; CD44; MICRORNA; ISOFORMS; BREAST; SOX2;
D O I
10.1074/jbc.M111.308528
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human head and neck squamous cell carcinoma (HNSCC) is a highly malignant cancer associated with major morbidity and mortality. In this study, we determined that human HNSCC-derived HSC-3 cells contain a subpopulation of cancer stem cells (CSCs) characterized by high levels of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression. These tumor cells also express several stem cell markers (the transcription factors Oct4, Sox2, and Nanog) and display the hallmark CSC properties of self-renewal/clonal formation and the ability to generate heterogeneous cell populations. Importantly, hyaluronan (HA) stimulates the CD44v3 (an HA receptor) interaction with Oct4-Sox2-Nanog leading to both a complex formation and the nuclear translocation of three CSC transcription factors. Further analysis reveals that microRNA-302 (miR-302) is controlled by an upstream promoter containing Oct4-Sox2-Nanog-binding sites, whereas chromatin immunoprecipitation (ChIP) assays demonstrate that stimulation of miR-302 expression by HA-CD44 is Oct4-Sox2-Nanog-dependent in HNSCC-specific CSCs. This process results in suppression of several epigenetic regulators (AOF1/AOF2 and DNMT1) and the up-regulation of several survival proteins (cIAP-1, cIAP-2, and XIAP) leading to self-renewal, clonal formation, and cisplatin resistance. These CSCs were transfected with a specific anti-miR-302 inhibitor to silence miR-302 expression and block its target functions. Our results demonstrate that the anti-miR-302 inhibitor not only enhances the expression of AOF1/AOF2 and DNMT1 but also abrogates the production of cIAP-1, cIAP-2, and XIAP and HA-CD44v3-mediated cancer stem cell functions. Taken together, these findings strongly support the contention that the HA-induced CD44v3 interaction with Oct4-Sox2-Nanog signaling plays a pivotal role in miR-302 production leading to AOF1/AOF2/DNMT1 down-regulation and survival of protein activation. All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, clonal formation, and chemotherapy resistance in HA-CD44v3-activated head and neck cancer.
引用
收藏
页码:32800 / 32824
页数:25
相关论文
共 70 条
[21]   Sox genes and cancer [J].
Dong, C ;
Wilhelm, D ;
Koopman, P .
CYTOGENETIC AND GENOME RESEARCH, 2004, 105 (2-4) :442-447
[22]   In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells [J].
Dontu, G ;
Abdallah, WM ;
Foley, JM ;
Jackson, KW ;
Clarke, MF ;
Kawamura, MJ ;
Wicha, MS .
GENES & DEVELOPMENT, 2003, 17 (10) :1253-1270
[23]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[24]   A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression [J].
Franzmann, EJ ;
Weed, DT ;
Civantos, FJ ;
Goodwin, WJ ;
Bourguignon, LYW .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 124 (04) :426-432
[25]   Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation [J].
Gontan, Cristina ;
de Munck, Anne ;
Vermeij, Marcel ;
Grosveld, Frank ;
Tibboel, Dick ;
Rottier, Robbert .
DEVELOPMENTAL BIOLOGY, 2008, 317 (01) :296-309
[26]   IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer [J].
Gyrd-Hansen, Mads ;
Meier, Pascal .
NATURE REVIEWS CANCER, 2010, 10 (08) :561-574
[27]   The role of hyaluronic acid in hemopoietic stem cell biology [J].
Haylock, David N. ;
Nilsson, Susan K. .
REGENERATIVE MEDICINE, 2006, 1 (04) :437-445
[28]   THE POU DOMAIN - VERSATILITY IN TRANSCRIPTIONAL REGULATION BY A FLEXIBLE 2-IN-ONE DNA-BINDING DOMAIN [J].
HERR, W ;
CLEARY, MA .
GENES & DEVELOPMENT, 1995, 9 (14) :1679-1693
[29]   Embryonic stem cell-specific MicroRNAs [J].
Houbaviy, HB ;
Murray, MF ;
Sharp, PA .
DEVELOPMENTAL CELL, 2003, 5 (02) :351-358
[30]   The inhibitors of apoptosis (IAPs) as cancer targets [J].
Hunter, Allison M. ;
LaCasse, Eric C. ;
Korneluk, Robert G. .
APOPTOSIS, 2007, 12 (09) :1543-1568